Condensed Consolidated Statements of Stockholders' Equity (unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)
Beginning Balance at Dec. 31, 2022	$ 110,679	$ 8	$ 350,980	$ (240,288)	$ (21)
Beginning Balance, Shares at Dec. 31, 2022		78,022,924
Stock-based compensation expense	2,449		2,449
Exercise of stock options, Shares		16,713
Vesting of RSUs, Shares		78,161
Other comprehensive income	23				23
Net loss	(20,711)			(20,711)
Ending Balance at Mar. 31, 2023	92,440	$ 8	353,429	(260,999)	$ 2
Ending Balance, Shares at Mar. 31, 2023		78,117,798
Beginning Balance at Dec. 31, 2023	58,532	$ 8	358,305	(299,781)
Beginning Balance, Shares at Dec. 31, 2023		78,356,527
Stock-based compensation expense	1,438		1,438
Exercise of stock options	$ 1		1
Exercise of stock options, Shares	207,238	204,053
Vesting of RSUs, Shares		124,284
Net loss	$ (9,763)			(9,763)
Ending Balance at Mar. 31, 2024	$ 50,208	$ 8	$ 359,744	$ (309,544)
Ending Balance, Shares at Mar. 31, 2024		78,684,864